Back
The Chemours Quote, Financials, Valuation and Earnings
Sponsored
CC
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
60
CC
The Chemours
Last Price:
27.32
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeThe Chemours Price Quote
$27.32
The Chemours Key Stats
Buy
60
The Chemours (CC)
is a Buy
Day range:
$26.49 - $27.33
52-week range:
$15.10 - $39.05
Dividend yield:
3.66%
P/E ratio:
0.00
P/S ratio:
0.69
P/B ratio:
5.52%
Volume:
776.6K
Avg. volume:
1.6M
1-year change:
0.04%
Market cap:
$4.1B
Revenue:
$6B
EPS:
$-1.61
How Much Does The Chemours Make?
-
How Much Are The Chemours's Sales Annually?
CC Revenues are $6B -
How Much Profit Does The Chemours's Make A Year?
CC net income is -$238M
Is The Chemours Growing As A Company?
-
What Is The Chemours's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is The Chemours's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
The Chemours Stock Price Performance
-
Did The Chemours Stock Go Up Last Month?
The Chemours share price went down by -0.18% last month -
Did CC's Share Price Rise Over The Last Year?
CC share price rose by 0.04% over the past 1 year
What Is The Chemours 52-Week High & Low?
-
What Is The Chemours’s 52-Week High Share Price?
The Chemours has traded as high as $39.05 over the past 52 weeks -
What Is The Chemours’s 52-Week Low Share Price?
The Chemours has traded as low as $15.10 over the past 52 weeks
The Chemours Price To Free Cash Flow
-
Is The Chemours Stock Overvalued?
The Chemours is trading at a price to free cash flow ratio of 22.38 -
Is The Chemours Stock Undervalued?
The Chemours EV to Free Cash Flow ratio is 37.12 -
What Is The Chemours’s Price Earnings Growth Ratio?
CC PEG ratio is 0.00 -
Is The Chemours Trading At A Premium To Earnings?
The Chemours EV to EBIT ratio is 0.00
Is It Risky To Buy The Chemours?
-
How Much Debt Does The Chemours Have?
Total long term debt quarterly is $4B -
How Much Cash Does The Chemours Have?
Cash and short term investments quarterly total is $1.2B -
What Is The Chemours’s Book Value Per Share?
Book value per share is 4.96
Is The Chemours Cash Flow Positive?
-
What Is CC Cash Flow From Operations?
Cash flow from operations (TTM) is $556M -
What Is The Chemours’s Cash Flow From Financing?
Cash flow from financing (TTM) is $172M -
What Is The Chemours’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$229M
The Chemours Return On Invested Capital
-
Is Management Doing A Good Job?
CC return on invested capital is -5.04% -
What Is The Chemours Return On Assets?
ROA measures how assets are converting to revenues and is -3.03% -
What Is CC Return On Equity?
ROE is a measure of profitability and is -25.53%
The Chemours Earnings Date & Stock Price
-
What Is The Chemours's Stock Price Today?
A single share of CC can be purchased today for 27.32 -
What Is The Chemours’s Stock Symbol?
The Chemours trades on the nyse under the ticker symbol: CC -
When Is The Chemours’s Next Earnings Date?
The next quarterly earnings date for The Chemours is scheduled on April 30, 2024 -
When Is CC's next ex-dividend date?
The Chemours's next ex-dividend date is February 23, 2024 -
How To Buy The Chemours Stock?
You can buy The Chemours shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
The Chemours Competitors
-
Who Are The Chemours's Competitors?
Below is a list of companies who compete with The Chemours or are related in some way:
The Chemours Dividend Yield
-
What Is CC Dividend Yield?
The Chemours’s dividend yield currently is 3.66% -
What Is The Chemours’s Payout Ratio?
The Chemours’s payout ratio is -62.87% -
When Did The Chemours Last Pay A Dividend?
The latest dividend pay date is April 28, 2024 -
What Is The Chemours’s Dividend Per Share?
The Chemours pays a dividend of $0.25 per share
The Chemours Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 30.87% |
Revenue: | 1.72% | 1.91% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 31.27 |
Upside from Last Price: | 14.46% |